Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68-VMT02

A radioconjugate composed of the melanocyte-stimulating hormone receptor (MSHR; melanocortin-1 receptor; MC1R; melanin-activating peptide receptor; melanotropin receptor)-targeting moiety, VMT02, labeled with the radioisotope gallium Ga 68, with potential imaging activity using positron emission tomography (PET). Upon administration of gallium Ga 68-VMT02, VMT02 targets and binds to MC1R-expressing tumor cells. Upon PET imaging, MC1R-expressing tumor cells can be detected. MC1R, a G protein-coupled receptor expressed by melanocytes that binds to melanocortins, is involved in regulating mammalian skin and hair color. It is upregulated on the surface of metastatic melanoma cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:[68Ga]-VMT02
[68Ga]VMT02
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search